Currently available therapeutic strategies for pulmonary arterial hypertension are often not successful in preventing significant disease progression or death. This study shows that activation of pulmonary ACE2 enzyme by a newly discovered small synthetic molecule prevents pulmonary hypertension and vascular remodeling, and suggests that pulmonary ACE2 may be a novel target for the successful control of pulmonary hypertension.